Xyosted 50 MG/0.5 ML auto-INJ 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FU644
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,088
Award facts
- Contract value 100% obligated
- $1,088.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,088.13 to AmerisourceBergen Drug Corp for Xyosted 50 mg/0.5 mL auto-injector supplies. The order was competitively awarded on December 11, 2025, with a completion date of December 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfilled this order without set-aside designation through open competition. The delivery order is consistent with the contractor's extensive portfolio of federal medical procurement activities supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Xyosted is a testosterone replacement therapy administered via auto-injector, representing the type of specialized pharmaceutical product that AmerisourceBergen regularly supplies through its DLA contracts across multiple therapeutic domains including endocrinology, neurology, pain management, and infectious disease treatments.
Quick answers
Who was awarded contract SPE2DR26FU644?
SPE2DR26FU644 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26FU644 worth?
The government has obligated $1,088 on SPE2DR26FU644.
Is contract SPE2DR26FU644 an order under another contract?
Yes. SPE2DR26FU644 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU644 competed?
The extent of competition for SPE2DR26FU644 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award